Genetic analysis in the clinical management of biliary tract cancer

Biliary tract cancer (BTC) is clinically and pathologically heterogeneous and responds inadequately to treatment. A small section of patients develop resectable disease, although the relapse rates are high; the benefits of adjuvant capecitabine chemotherapy for BTC are now understood, and gemcitabin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakai, Toshifumi, Nagahashi, Masayuki, Shimada, Yoshifumi, Prasoon, Pankaj, Sakata, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382432/
https://www.ncbi.nlm.nih.gov/pubmed/32724874
http://dx.doi.org/10.1002/ags3.12334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382432/
https://www.ncbi.nlm.nih.gov/pubmed/32724874
http://dx.doi.org/10.1002/ags3.12334

Ejemplares similares